Zura Bio Limited (ZURA)
(Real Time Quote from BATS)
$1.49 USD
-0.03 (-1.97%)
Updated Aug 7, 2025 03:38 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZURA 1.49 -0.03(-1.97%)
Will ZURA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZURA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZURA
Down -35.58% in 4 Weeks, Here's Why You Should You Buy the Dip in Zura Bio Limited (ZURA)
ZURA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ZURA
12 Health Care Stocks Moving In Thursday's Intraday Session
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ZURA Stock News
Zura Bio appoints Eric Hyllengren as CFO
Zura Bio Announces Chief Financial Officer Transition | ZURA Stock News
Zura Bio appoints Eric Hyllengren as CFO